Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Abbott

Abbott Agrees to Pay Nearly $385 Million Over Infant Formula Manufacturing Allegations

Abbott Laboratories has agreed to pay nearly $385 million to settle federal and state allegations involving the manufacture of certain powder infant formula and nutritional therapy products, including products purchased through government-funded nutrition programs.

Clever Dude · Sep 22

Beta Bionics Wins FDA Clearance for Mint Tubeless Insulin Patch Pump, Plans Pharmacy-Only U.S. Launch in Early 2027

The FDA cleared Beta Bionics' Mint tubeless insulin patch pump. What the clearance covers, when it launches, and what people with diabetes should know.

Medical Daily · Sep 16

Abbott Agrees to Pay Nearly $385 Million to Settle Claims Over Infant Formula Made in Michigan and Arizona

Abbott will pay $384,999,040 to settle False Claims Act allegations over infant formula from its Sturgis and Casa Grande plants. What parents should know.

Medical Daily · Sep 16

From analysis to the latest developments in health,
read the most diverse news in one place.

Abbott agrees to pay nearly $385 million to US government over alleged infant formula false claims

Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns. Abbott maintains that no distributed infant formula tested positive for Cronobacter and says government testing found…

The Times of India · Sep 14

Baby formula maker Abbott Labs agrees to settlement over closure of largest US plant

Abbott closed the Sturgis facility in February 2022 following the start of an investigation by the FDA

The Independent UK · Sep 14

Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?

Despite Abbott Laboratories' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart · Sep 1

Diabetes Wearable Cleared for Children as Young as Two Tracks Ketones and Blood Sugar from One Sensor

The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking ketones and glucose together, for people with diabetes aged 2 and up.

Medical Daily · Aug 26

Read news from The Economist, FT, and more,
with one subscription

Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott has lagged behind the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

Barchart · Aug 6

New blood test to detect colon cancer clears FDA approval

New cases of colorectal cancer and deaths have been rising in younger adults since the mid-2000s

The Independent UK · Aug 3

FDA Approves a Blood Test for Colorectal Cancer Screening That Misses Most Precancerous Growths

The FDA approved SimpleScreen CRC, a blood test for colorectal cancer screening. It detects cancer well but finds few precancerous lesions.

Medical Daily · Jul 30

This Dividend King Could Be One of the Safest Stocks to Own Right Now

Abbott's diversified healthcare business is one of the main reasons why it remains a reliable dividend stock.

Barchart · Jul 20

Trump DOJ Drops Corporate Crime Investigations, Giving Major Companies a Free Pass

The Trump Justice Department has dropped several high-profile corporate investigations, including an inquiry into Federal Reserve Chair Jerome Powell, fueling concerns over a pullback in enforcement.

International Business Times UK · Jul 20

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street

Abbott's Q2 results show solid organic growth, better-than-expected margins, and improved earnings guidance, easing concerns over the Exact Sciences acquisition and boosting ABT shares.

MarketBeat · Jul 16

Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised

Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outlook and reaffirmed revenue growth guidance. Progress across its medical devices and diagnostics pipeline further boosted investor confidence in future growth.

The Economic Times · Jul 16

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Jul 4

Infant Formula Makers Were Required to Tell the FDA When Babies Died — Records Show They Never Did

KFF Health News found the FDA received zero formula maker death notifications going back to 2000. Abbott's expert testified it never reported a single death for preterm formula.

Medical Daily · Jul 3

Premature Infants in NICUs Face a Higher Risk of NEC from Formula, Experts Warn

If your premature baby is in the NICU on cow's milk formula, ask about NEC risk now. Here are the specific questions to ask your neonatologist and what the evidence shows.

International Business Times UK · Jun 30

Abbott Laboratories Federal Formula Safety Probe Quietly Shelved Following Massive Cash Injection To Donald Trump Fund

The US Justice Department has ended its criminal investigation into Abbott Laboratories' contaminated baby formula plant, opting for civil penalties instead, amid scrutiny over political donations.

International Business Times UK · Jun 29

DOJ Dropped Secret Criminal Charges Against Baby Formula Giant Abbott Despite Claims Contaminated Milk 'Sickened And Killed' Infants

The Justice Department has closed its criminal investigation into Abbott Laboratories, opting for civil penalties over charges related to the 2022 baby formula contamination and shortage.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Jun 26

Abbott Laboratories' Q2 2026 Earnings: What to Expect

Abbott Laboratories is scheduled to report its second-quarter results in July, and analysts expect a single-digit earnings rise.

Android Central · Jun 18

Ultrahuman seeks to define: M2 Live keeps your metabolic health close with a small sensor

Ultrahuman launches M2 Live with Abbott's Lingo biosensor to help users take their glucose (metabolic health) more seriously with a continuous monitor.

TechRadar · Jun 12

Hate giving blood? Samsung’s latest VR demo will help you meditate while donating — and it’s given me some ideas

Samsung’s XR headset might help you relax the next time you give blood, thanks to VR meditation.

MarketBeat · Jun 3

MiniMed Group Q4 Earnings Call Highlights

MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first earnings call as a standalone public company following its March IPO. Chief Executive Officer Que Dallar

Barchart · May 27

3 Ultra-Reliable Dividend Kings Trading at Bargain-Basement Prices

These beaten-down Dividend Kings, trading near their 2026 lows, offer income, rebound potential, and Wall Street-backed upside for patient investors.

Barchart · May 22

Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity

While ABT stock appears poised to reach the year’s halfway mark in ignominy, the options market is quietly signaling a possible recovery.

Fortune · May 17

Gen X is the most indebted generation in America. Their employers can fix that

Student loan matching programs are on the books. Does your company have one?

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

the American Academy of Pediatrics

106 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.